FluoGuide A/S (STO:FLUO)
Sweden · Delayed Price · Currency is SEK 34.40
-1.40 (-3.91%)
Mar 2, 2026, 3:26 PM CET
FluoGuide Market Cap
FluoGuide has a market cap or net worth of 562.42 million as of March 2, 2026. Its market cap has decreased by -15.56% in one year.
Market Cap
562.42M
Enterprise Value
489.22M
Revenue
318.79K
Ranking
n/a
PE Ratio
n/a
Stock Price
34.40
Market Cap Chart
Since May 13, 2019, FluoGuide's market cap has increased from 40.02M to 562.42M, an increase of 1,305.25%. That is a compound annual growth rate of 47.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 585.31M | 4.37% |
| Dec 30, 2025 | 560.78M | 5.17% |
| Dec 30, 2024 | 533.23M | -28.57% |
| Dec 29, 2023 | 746.52M | 68.50% |
| Dec 30, 2022 | 443.04M | -54.38% |
| Dec 30, 2021 | 971.21M | 4.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovis AB (publ.) | 1.14B |
| Xspray Pharma AB | 1.09B |
| SynAct Pharma AB | 1.05B |
| Medivir AB | 864.03M |
| Infant Bacterial Therapeutics AB | 677.61M |
| Oncopeptides AB | 463.60M |
| Corline Biomedical AB | 405.97M |
| Ascelia Pharma AB | 397.73M |